Pharsight

1. Nicoderm Cq patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5508038	CHATTEM SANOFI	Polyisobutylene adhesives for transdermal devices	Apr, 2013 (11 years ago)
US9205059	CHATTEM SANOFI	Transparent transdermal nicotine delivery devices	Dec, 2019 (4 years ago)
US8999379	CHATTEM SANOFI	Transparent transdermal nicotine delivery devices	Feb, 2020 (4 years ago)
US8663680	CHATTEM SANOFI	Transparent transdermal nicotine delivery devices	Feb, 2020 (4 years ago)
US8075911	CHATTEM SANOFI	Transparent transdermal nicotine delivery devices	May, 2021 (2 years ago)

Market Authorisation Date: 02 August, 1996

Treatment: A method to reduce withdrawal symptoms, including nicotine craving, associated with smoking cessation

Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
7 mg/24 hrs 14 mg/24 hrs 21 mg/24 hrs	30 May, 2014	1		22 May, 2021	Extinguished

Strength	Dosage	Availability
14MG/24HR	FILM, EXTENDED RELEASE;TRANSDERMAL	Over the counter
7MG/24HR	FILM, EXTENDED RELEASE;TRANSDERMAL	Over the counter
21MG/24HR	FILM, EXTENDED RELEASE;TRANSDERMAL	Over the counter

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry	Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5656255	PFIZER INC	Composition to help stop smoking	Aug, 2014 (9 years ago)

Market Authorisation Date: 22 March, 1996

Treatment: NA

Dosage: SPRAY, METERED;NASAL